Xinyi Biotech recently announced that it has received an investment of 100 million yuan from the Beijing Pharmaceutical Fund. Xinyi Biotech's current support from the Beijing Pharmaceutical Fund will accelerate the company's clinical registration of digital PCR and molecular POCT series reagent products. According to information, the Beijing Medical and Health Industry Investment Fund is a government investment fund in the medical and health industry established by Beijing at the end of 2023 that focuses on key industries such as innovative drugs and innovative medical devices, as well as emerging industries such as cell and gene therapy and digital medicine.
新羿生物日前宣布获北京医药基金1亿元投资。新羿生物本次获北京市医药基金支持将加速公司在数字PCR及分子POCT系列试剂产品的临床注册。据了解北京市医药健康产业投资基金是2023年底北京市设立的医药健康产业领域政府投资基金重点投向创新药、创新医疗器械等重点产业领域以及细胞与基因治疗、数字医疗等新兴产业领域。
Xinyi Biotech recently announced that it has received an investment of 100 million yuan from the Beijing Pharmaceutical Fund. Xinyi Biotech's current support from the Beijing Pharmaceutical Fund will accelerate the company's clinical registration of digit
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.